Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Plus Therapeutics - 24 Year Stock Price History | PSTV

Historical daily share price chart and data for Plus Therapeutics since 2001 adjusted for splits and dividends. The latest closing stock price for Plus Therapeutics as of November 14, 2025 is 0.51.
  • The all-time high Plus Therapeutics stock closing price was 1000000.00 on November 11, 2005.
  • The Plus Therapeutics 52-week high stock price is 2.31, which is 352.9% above the current share price.
  • The Plus Therapeutics 52-week low stock price is 0.16, which is 68.6% below the current share price.
  • The average Plus Therapeutics stock price for the last 52 weeks is 0.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Plus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.6916 1.1800 1.5700 0.1800 0.5115 -55.52%
2024 1.6851 1.8500 2.6000 0.9900 1.1500 -34.29%
2023 3.2082 4.6500 7.2000 1.0100 1.7500 -63.54%
2022 10.1056 16.3500 19.8000 4.5000 4.8000 -69.52%
2021 32.4524 31.6500 56.2500 15.4500 15.7500 -48.02%
2020 32.6496 39.7500 47.5500 15.7500 30.3000 -15.83%
2019 149.1429 240.0000 292.5000 29.8500 36.0000 -83.45%
2018 1318.1175 2175.0000 3750.0000 202.5000 217.5000 -90.33%
2017 6779.8805 12000.0000 14925.0000 1725.0000 2250.0000 -80.13%
2016 18043.7500 21375.0000 39375.0000 10200.0000 11325.0000 -47.02%
2015 65593.7500 58500.0000 154125.0000 21375.0000 21375.0000 -61.22%
2014 206080.3571 283500.0000 373500.0000 42750.0000 55125.0000 -80.93%
2013 284066.9643 319500.0000 376875.0000 231750.0000 289125.0000 -8.21%
2012 340681.5000 256500.0000 534375.0000 228375.0000 315000.0000 27.27%
2011 526084.8214 606375.0000 928125.0000 221625.0000 247500.0000 -57.61%
2010 588619.0476 699750.0000 1000000.0000 383625.0000 583875.0000 -14.92%
2009 390647.3214 405000.0000 739125.0000 175500.0000 686250.0000 68.98%
2008 604405.1383 687375.0000 963000.0000 212625.0000 406125.0000 -40.33%
2007 640801.7928 720000.0000 745875.0000 523125.0000 680625.0000 -7.49%
2006 724109.5618 931500.0000 1000000.0000 451125.0000 735750.0000 -21.20%
2005 509188.9881 267750.0000 1000000.0000 258750.0000 933750.0000 201.82%
2004 380107.1429 343125.0000 506250.0000 281250.0000 309375.0000 -9.84%
2003 400209.8214 450000.0000 502875.0000 326250.0000 343125.0000 -23.75%
2002 418138.3929 378000.0000 562500.0000 309375.0000 450000.0000 25.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.070B $0.006B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.048B 33.06
Zoetis (ZTS) United States $53.245B 19.06
Takeda Pharmaceutical (TAK) Japan $45.470B 9.28
BeOne Medicines - (ONC) Switzerland $43.363B 212.69
Daiichi Sankyo, - (DSNKY) Japan $42.699B 21.26
Sandoz Group AG (SDZNY) Switzerland $30.385B 0.00
United Therapeutics (UTHR) United States $20.082B 17.67
Merck (MKKGY) Germany $17.810B 10.98
Shionogi (SGIOY) Japan $14.955B 13.73
Neurocrine Biosciences (NBIX) United States $14.443B 34.66
Summit Therapeutics (SMMT) United States $13.904B 0.00
IPSEN (IPSEY) France $12.822B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.019B 0.00
Ionis Pharmaceuticals (IONS) United States $11.589B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.586B 0.00
Corcept Therapeutics (CORT) United States $7.946B 85.84
Stevanato Group S.p.A (STVN) Italy $6.687B 37.42
Grifols, S.A (GRFS) Spain $5.989B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.349B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.049B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.711B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.659B 17.37
Hypermarcas (HYPMY) Brazil $3.040B 20.87
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.849B 9.09
Dyne Therapeutics (DYN) United States $2.684B 0.00
Soleno Therapeutics (SLNO) United States $2.654B 0.00
Ocular Therapeutix (OCUL) United States $2.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.024B 23.98
Guardian Pharmacy Services (GRDN) United States $1.850B 35.62
Harrow (HROW) United States $1.511B 92.71
BioCryst Pharmaceuticals (BCRX) United States $1.491B 88.50
Collegium Pharmaceutical (COLL) United States $1.453B 7.20
Ardelyx (ARDX) United States $1.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.394B 0.00
Oruka Therapeutics (ORKA) United States $1.311B 0.00
Enliven Therapeutics (ELVN) United States $1.310B 0.00
Xeris Biopharma Holdings (XERS) United States $1.191B 0.00
Nektar Therapeutics (NKTR) United States $1.153B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Evotec AG (EVO) Germany $1.074B 0.00
Xencor (XNCR) United States $1.066B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
Theravance Biopharma (TBPH) United States $0.881B 37.00
Savara (SVRA) United States $0.875B 0.00
ARS Pharmaceuticals (SPRY) United States $0.812B 0.00
Organogenesis (ORGO) United States $0.774B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.761B 6.80
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
ProKidney (PROK) United States $0.709B 0.00
Esperion Therapeutics (ESPR) United States $0.693B 0.00
KalVista Pharmaceuticals (KALV) United States $0.688B 0.00
Lexeo Therapeutics (LXEO) United States $0.660B 0.00
Aquestive Therapeutics (AQST) United States $0.658B 0.00
4D Molecular Therapeutics (FDMT) United States $0.616B 0.00
Bioventus (BVS) United States $0.608B 12.46
Ironwood Pharmaceuticals (IRWD) United States $0.510B 12.08
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.430B 5.88
Nature's Sunshine Products (NATR) United States $0.370B 22.05
Lyell Immunopharma (LYEL) United States $0.359B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
USANA Health Sciences (USNA) United States $0.351B 9.79
Silence Therapeutics (SLN) United Kingdom $0.323B 0.00
Aldeyra Therapeutics (ALDX) United States $0.304B 0.00
Larimar Therapeutics (LRMR) United States $0.280B 0.00
Avalo Therapeutics (AVTX) United States $0.274B 0.00
Aclaris Therapeutics (ACRS) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.271B 0.00
Achieve Life Sciences (ACHV) Canada $0.233B 0.00
OmniAb (OABI) United States $0.225B 0.00
AleAnna (ANNA) United States $0.220B 0.00
Protara Therapeutics (TARA) United States $0.213B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.139B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Cassava Sciences (SAVA) United States $0.133B 0.00
Relmada Therapeutics (RLMD) United States $0.131B 0.00
Incannex Healthcare (IXHL) Australia $0.123B 0.00
Unicycive Therapeutics (UNCY) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Prelude Therapeutics (PRLD) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Acrivon Therapeutics (ACRV) United States $0.071B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Fractyl Health (GUTS) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
Korro Bio (KRRO) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.38
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
Heatwurx (PCSA) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.56
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00